caprylates has been researched along with darunavir in 1 studies
| Studies (caprylates) | Trials (caprylates) | Recent Studies (post-2010) (caprylates) | Studies (darunavir) | Trials (darunavir) | Recent Studies (post-2010) (darunavir) |
|---|---|---|---|---|---|
| 5,061 | 100 | 2,339 | 1,148 | 224 | 780 |
| Protein | Taxonomy | caprylates (IC50) | darunavir (IC50) |
|---|---|---|---|
| Chain A, HIV-1 protease | Human immunodeficiency virus 1 | 0.0028 | |
| Chain B, HIV-1 protease | Human immunodeficiency virus 1 | 0.0028 | |
| Chain A, HIV-1 protease | Human immunodeficiency virus 1 | 0.0028 | |
| Chain B, HIV-1 protease | Human immunodeficiency virus 1 | 0.0028 | |
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | 6.6 | |
| Protease | Human immunodeficiency virus 1 | 0.063 | |
| Protease | Human immunodeficiency virus 1 | 0.0014 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bandari, S; Dhurke, R; Eedara, BB; Inugala, S; Jukanti, R; Kandadi, P; Sunkavalli, S | 1 |
1 other study(ies) available for caprylates and darunavir
| Article | Year |
|---|---|
Solid self-nanoemulsifying drug delivery system (S-SNEDDS) of darunavir for improved dissolution and oral bioavailability: In vitro and in vivo evaluation.
Topics: Administration, Oral; Animals; Biological Availability; Caprylates; Darunavir; Delayed-Action Preparations; Drug Delivery Systems; Drug Liberation; Drug Stability; Emulsions; Ethylene Glycols; Excipients; Glycerides; Half-Life; HIV Protease Inhibitors; Male; Nanostructures; Particle Size; Polysorbates; Random Allocation; Rats, Wistar; Surface Properties; Surface-Active Agents | 2015 |